DOTAREM (Guerbet LLC)


Welcome to the PulseAid listing for the DOTAREM drug offered from Guerbet LLC. This Gadolinium-based Contrast Agent [EPC],Magnetic Resonance Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Guerbet LLC
NON-PROPRIETARY NAME: gadoterate meglumine
SUBSTANCE NAME: GADOTERATE MEGLUMINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Gadolinium-based Contrast Agent [EPC],Magnetic Resonance Contrast Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-03-20
END MARKETING DATE: 0000-00-00


DOTAREM HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDOTAREM from Guerbet LLC
LABELER NAME: Guerbet LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 376.9(mg/mL)
START MARKETING DATE: 2013-03-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67684-2000_c205ab10-1eda-46aa-8b40-6a1b8d83ec56
PRODUCT NDC: 67684-2000
APPLICATION NUMBER: NDA204781

Other GADOTERATE MEGLUMINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Guerbet LLCDOTAREM